Food & Drug Law Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Food & Drug Law Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Alba Therapeutics Corporation
Biopharmaceutical firm signs supply agreement with Solvay
September 24th, 2004
Alba Therapeutics Corporation, of Baltimore, Maryland, announced that it has recently signed a supply agreement with Solvay, SA, through its affiliate, Peptisyntha, Belgium. As Alba's manufacturing development partner, Peptisyntha will lead the manufacturing process development of Alba's upcoming products. "Alba is pleased to partner with a company of Peptisyntha's caliber, depth and breadth in peptide manufacturing, and we are honored that they have demonstrated a substantial commitment to our business model and management team, stated Blake Paterson, MD, Alba's cofounder, president and CEO. Additionally, Alba Therapeutics...
Source: Food & Drug Law Weekly (2004-09-24)
|
